Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 123 (RPL21P123)

Target
RPL21P123
Molecular classification
Other (Pseudogene)
01

Overview

RPL21P123 is a human processed pseudogene derived from the ribosomal protein L21 gene family. Pseudogenes are genomic DNA sequences similar to known genes but generally non-functional due to accumulation of mutations or lack of regulatory elements. RPL21P123 does not encode a functional protein and is not considered a molecular target for drugs or therapeutic intervention. Its name reflects its relationship to the ribosomal protein L21, which is a component of the 60S ribosomal subunit involved in cellular protein synthesis. There is no evidence of direct biological function, disease association, or relevance as a biomarker or pharmacological target for RPL21P123. Any information regarding function or drug interaction refers instead to the parent gene RPL21.

Other names
RPL21P123RPL21_59_1535
02

Mechanism of action

None (no known mechanism, as not a druggable target)

03

Biological functions

Other (No known biological function; pseudogene)
04

Disease associations

Other (No direct association with disease; RPL21, the parent gene, is associated with hypotrichosis)
05

Safety considerations

None (not therapeutically targeted)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 123 (RPL21P123).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 123 (RPL21P123).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call